Related Experiment Video
Updated: Mar 7, 2026

A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection
Published on: August 14, 2019
Influenza vaccination in north Indian patients with heart failure
Parvaiz A Koul1, Saima Ali2, Hyder Mir2
1Department of Internal & Pulmonary Medicine, Sher I Kashmir Institute of Medical Sciences, Srinagar, India. Electronic address: http://www.skims.ac.in.
Background:
No data exists regarding the uptake of influenza vaccination in patients with heart failure (HF) in India. The present study was designed to assess the uptake, knowledge, attitude and practices of the Indian HF patients towards influenza vaccination.
Methods And Results:
Five-hundred patients with acute/chronic HF were approached for a personal interview and responses to an interview recorded in a pre-defined questionnaire depicting their knowledge, attitudes and practice regarding influenza vaccination. Of the 500 approached, 320 (64%, 174 male, age 3-90 years) consented to participate in the survey. Only 7.5% (n=24) knew of influenza as an illness with adverse potential consequences for themselves or their family. Seventeen (5.3%) were aware of potentially serious nature of influenza and 40 (12.5%) knew of the availability of a vaccine against it and its local availability. However only 14 (4.4%) had actually received the vaccine 1-2 times in the past 5 years. Only 21 (6.56%) had been prescribed influenza vaccine by their respective physicians. Reasons for declining vaccination included misperceptions about safety and efficacy of the vaccine. Most of the participants, however, had not been prescribed vaccination at all.
Conclusions:
Poor influenza vaccination rates in HF mandate intense efforts to improve vaccination rates.
More Related Videos
06:34An Optimized Hemagglutination Inhibition HI Assay to Quantify Influenza-specific Antibody Titers
Published on: December 1, 2017
09:31Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals
Published on: April 15, 2017
Related Concept Videos
Heart Failure V: Medical Management
Rheumatic Heart Disease III: Medical Management
Heart Failure Drugs: Inotropic Agents
Rheumatic Heart Disease IV: Nursing Management
Heart Failure Drugs: β-Blockers
Heart Failure III: Clinical Manifestations